HALO
Halozyme Therapeutics Inc
Price:  
38.64 
USD
Volume:  
1,258,838.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HALO Stock Forecast & Price Target

HALO Stock Price Forecast

The average stock forecast for Halozyme Therapeutics Inc (HALO) in the next 12 months is 52.13 USD. This price target corresponds to an upside of 34.92%. The range of stock forecasts for HALO is 39.39 - 75.60 USD. Based on the ratings of 17 analysts, the consensus recommendation for HALO is BUY.
Target Low Average Median High
Price (USD) 39.39 52.13 51.00 75.60
Upside 1.94% 34.92% 31.99% 95.65%

Recommendation Trends

The latest consensus rating for HALO is "BUY". This is the average recommendation of 17 analysts: 0 strong sell, 0 sell, 3 hold, 12 buy, 2 strong buy. In the previous period, 18 analysts also majorly recommmended "BUY" for HALO.

HALO Financial Stock Forecast

Revenue This Year
954.35M
15.09%
from 829.25M
Revenue Next Year
1,083.84M
13.57%
from 954.35M
EPS This Year
3.80
71.33%
from 2.22
EPS Next Year
4.70
23.74%
from 3.80